Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cherubin Manokaran"'
Publikováno v:
Trends in Pharmacological Sciences. 44:67-69
STING (stimulator of interferon genes) activation has considerable potential as a new strategy for cancer therapy, but clinical results have not been encouraging. Recent studies explain why STING agonists often fail to regress human tumors and propos
Autor:
Thomas M. Roberts, Jean J. Zhao, Massimo Loda, Guo-Cheng Yuan, Sabina Signoretti, Isha Sethi, Yi Yang, Raymond Pagliarini, Lan Jiang, Fabienne Schmit, Zhigang Wang, Joshua M. Korn, Manav Korpal, Shidong Jia, Onur Cizmecioglu, Silvia Rodrigues, Thanh Von, Hyeyoun Chang, Cherubin Manokaran, Caroline F. Ribeiro, Yubao Wang, Xueliang Gao
Supplementary Table from Blocking PI3K p110β Attenuates Development of PTEN-Deficient Castration-Resistant Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20cef1f671739e29898e6794e46088ad
https://doi.org/10.1158/1541-7786.22527902
https://doi.org/10.1158/1541-7786.22527902
Autor:
Thomas M. Roberts, Jean J. Zhao, Massimo Loda, Guo-Cheng Yuan, Sabina Signoretti, Isha Sethi, Yi Yang, Raymond Pagliarini, Lan Jiang, Fabienne Schmit, Zhigang Wang, Joshua M. Korn, Manav Korpal, Shidong Jia, Onur Cizmecioglu, Silvia Rodrigues, Thanh Von, Hyeyoun Chang, Cherubin Manokaran, Caroline F. Ribeiro, Yubao Wang, Xueliang Gao
Supplementary Data from Blocking PI3K p110β Attenuates Development of PTEN-Deficient Castration-Resistant Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63af032d9cbd4d431caa25fcdc1d3af0
https://doi.org/10.1158/1541-7786.22527914.v1
https://doi.org/10.1158/1541-7786.22527914.v1
Autor:
Thomas M. Roberts, Jean J. Zhao, Massimo Loda, Guo-Cheng Yuan, Sabina Signoretti, Isha Sethi, Yi Yang, Raymond Pagliarini, Lan Jiang, Fabienne Schmit, Zhigang Wang, Joshua M. Korn, Manav Korpal, Shidong Jia, Onur Cizmecioglu, Silvia Rodrigues, Thanh Von, Hyeyoun Chang, Cherubin Manokaran, Caroline F. Ribeiro, Yubao Wang, Xueliang Gao
Supplementary Figure from Blocking PI3K p110β Attenuates Development of PTEN-Deficient Castration-Resistant Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16ee2c6ec730da34e869cffe1113668e
https://doi.org/10.1158/1541-7786.22527908
https://doi.org/10.1158/1541-7786.22527908
Autor:
Xueliang Gao, Yubao Wang, Caroline F. Ribeiro, Cherubin Manokaran, Hyeyoun Chang, Thanh Von, Silvia Rodrigues, Onur Cizmecioglu, Shidong Jia, Manav Korpal, Joshua M. Korn, Zhigang Wang, Fabienne Schmit, Lan Jiang, Raymond Pagliarini, Yi Yang, Isha Sethi, Sabina Signoretti, Guo-Cheng Yuan, Massimo Loda, Jean J. Zhao, Thomas M. Roberts
Publikováno v:
Molecular Cancer Research
Mol Cancer Res
Mol Cancer Res
A common outcome of androgen deprivation in prostate cancer therapy is disease relapse and progression to castration-resistant prostate cancer (CRPC) via multiple mechanisms. To gain insight into the recent clinical findings that highlighted genomic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::417496ddabb9a0b6f08cefe8db0057fc
https://hdl.handle.net/11693/111708
https://hdl.handle.net/11693/111708